
GSK319347A
CAS No. 862812-98-4
GSK319347A( —— )
Catalog No. M33384 CAS No. 862812-98-4
GSK319347A is a selective and potent dual inhibitor of TBK1 and IKKε with potential anti-tumor activity and inhibition of IKK2 activity, which can be used in the study of bladder cancer and lung adenocarcinoma.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 102 | Get Quote |
![]() ![]() |
5MG | 147 | Get Quote |
![]() ![]() |
10MG | 255 | Get Quote |
![]() ![]() |
25MG | 518 | Get Quote |
![]() ![]() |
50MG | 881 | Get Quote |
![]() ![]() |
100MG | 1152 | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameGSK319347A
-
NoteResearch use only, not for human use.
-
Brief DescriptionGSK319347A is a selective and potent dual inhibitor of TBK1 and IKKε with potential anti-tumor activity and inhibition of IKK2 activity, which can be used in the study of bladder cancer and lung adenocarcinoma.
-
DescriptionGSK319347A is a dual inhibitor of TBK1 and IKKε with IC50s of 93 nM and 469 nM, respectively. GSK319347A also inhibits IKK2 with an IC50 of 790 nM.
-
In VitroGSK319347A (Compound 1) inhibits TBK1 enzyme with an IC50 of 93 nM, which also translates into good cell potency (72 nM). Moreover, IKK-3 Inhibitor exhibits excellent selectivity against cell-cycle kinases CDK2 and AurB. IKK-3 Inhibitor (Compound 13) is a novel IκB kinase 2 (IKK2) inhibitor with an IC50 of 790 nM.
-
In Vivo——
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetIκB kinase (IKK)
-
RecptorIκB/IKK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number862812-98-4
-
Formula Weight469.53
-
Molecular FormulaC22H19N3O5S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 45 mg/mL (95.84 mM; Ultrasonic )
-
SMILESCOc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(s3)C#N)c2cc1OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Johannes JW, et al. Discovery of 6-aryl-azabenzimidazoles that inhibit the TBK1/IKK-ε kinases. Bioorg Med Chem Lett. 2014 Feb 15;24(4):1138-43.?
molnova catalog



related products
-
MLN120B
MLN120B is a selective and ATP competitive IKKβ inhibitor (IC50: 60 nM).MLN120B almost completely blocks the stimulation of MM.1S, U266, and INA6 cell growth, as well as IL-6 secretion from BMSCs, induced by multiple myeloma cell adherence to BMSCs [1]. MLN120B shows an inhibitory effect on LPS induced NF-κB activation in RAW267.4 cells.
-
BAY32-5915
BAY32-5915 is a selective inhibitor of IKKalpha.
-
PIAA
PIAA is a TBK1/IKKε inhibitor with IC50 of 0.40/1.07 uM, selectively accelerates proliferation of β-cells.